Search for a command to run...
BridgeBio Pharma, Inc.
Biotechnology
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Nov 2, 2026 | Gilbert CisnerosD | Stock | Buy |
| $1,001 - $15,000 |
| $75.00 |
| - |
| - |
| - |
Oct 27, 2026 | Gilbert CisnerosD | Stock | Buy | $1,001 - $15,000 | $69.37 | - | - | - |
Sep 29, 2026 | Gilbert CisnerosD | Stock | Sell | $1,001 - $15,000 | $65.97 | $70.73 | +7.2% | +6.5% |
May 11, 2026 | Gilbert CisnerosD | Stock | Buy | $1,001 - $15,000 | $64.68 | $67.40 | +4.2% | +6.1% |
Apr 29, 2026 | Gilbert CisnerosD | Stock | Buy | $1,001 - $15,000 | $70.94 | $66.26 | -6.6% | -12.9% |
Mar 19, 2026 | Gilbert CisnerosD | Stock | Buy | $1,001 - $15,000 | $70.07 | $76.75 | +9.5% | +1.6% |
Mar 18, 2026 | Gilbert CisnerosD | Stock | Buy | $1,001 - $15,000 | $70.12 | $76.75 | +9.5% | +1.8% |
Mar 3, 2026 | Gilbert CisnerosD | Stock | Buy | $1,001 - $15,000 | $64.53 | $73.15 | +13.4% | +16.7% |
Sep 22, 2025 | Gilbert CisnerosD | Stock | Buy | $1,001 - $15,000 | $51.54 | $53.24 | +3.3% | +3.2% |
Aug 8, 2025 | Gilbert CisnerosD | Stock | Buy | $1,001 - $15,000 | $46.58 | $53.38 | +14.6% | +13.0% |
Global Gene Therapy for Hearing Loss Market Report 2026 | Capture Growth to $1.71B by 2030 as Regeneron, Lilly, Sensorion and Astellas Advance AAV, CRISPR and Cochlear Delivery
BridgeBio to Participate in November and December Investor Conferences
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BridgeBio to Present New Acoramidis Data on Heart Failure Events in ATTR-CM at the American Heart Association Scientific Sessions 2026
Recursion Appoints Fred Hassan as Chair of the Board